Gujarat Terce Laboratories share news, announcements and annual reports
BSE: 524314Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹40.00.
28 Oct: open ₹40.00, high ₹42.80, low ₹37.02
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹33 Cr3,856th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.59
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 12.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.35
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 25.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 31.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 25.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,833
Gujarat Terce Laboratories has 523 announcements on record, routine notices left out; none in the 30 days to 28 Oct 2026, the latest on 21 Aug 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Gujarat Terce Laboratories quarterly results
The board met on 7 Aug 2026 to consider quarterly results
Notice filed 3 Aug 2026
Gujarat Terce Laboratories annual reports, presentations and earnings calls
The company's own documents, latest first.Gujarat Terce Laboratories financials, year by year
Annual reports28
- Annual report, year to Mar 202628 Jul 2026
- Annual report, year to Mar 202528 Jul 2025
- Annual report, year to Mar 202424 Aug 2024
- Annual report, year to Mar 20231 Aug 2023
- Annual report, year to Mar 20221 Aug 2022
23 earlier reports
- Annual report, year to Mar 202111 Aug 2021
- Annual report, year to Mar 202029 Jul 2020
- Annual report, year to Mar 201913 Aug 2019
- Annual report, year to Mar 201825 Sep 2018
- Annual report, year to Mar 201728 Sep 2017
- Annual report, year to Mar 201617 Oct 2016
- Annual report, year to Mar 20152 Sep 2015
- Annual report, year to Mar 201411 Sep 2014
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 2011Filing day not known
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Investor presentations19
- Detailed disclosure is attached.3 Jun 2026
- Investor Presentation for third quarter and nine months ended on 31 December 20254 Feb 2026
- Investor Presentation for the quarter and half year ....8 Nov 2025
- Investor Presentation for the quarter ended 30.06.2025.12 Aug 2025
- Investor Presentation for the year ended 31.03.202526 May 2025
14 earlier presentations
- Updated Investor Presentation for the quarter ended December 31, 2024. We would like to inform that the following changes have been made in Investor Presentation: ' in lacs instead of ....10 Feb 2025
- Investor Presentation for the quarter ended 31.12.2024.4 Feb 2025
- Investors Presentation for the quarter and half year ended 30th September, 202428 Oct 2024
- Investor Presentation for the quarter ended on 30th June, 2024.9 Aug 2024
- Investor Presentation for quarter ended on 31st March, 2024.29 May 2024
- Please find enclosed herewith Investor Presentation for the quarter ended on December 31, 2023.5 Feb 2024
- Investor Presentation for the quarter ended on March 31, 2023.13 May 2023
- Board of Directors, on recommendation of Nomination and Remuneration Committee of the Company, on May 31, 2023, have considered and approved the re-appointment of Mr. Surendra kumar ....13 May 2023
- Investor Presentation for the quarter that ended ....31 Jan 2023
- Investor Presentation for the quarter ended on ....14 Nov 2022
- Investor Presentation for the quarter ended on June ....5 Aug 2022
- Investor Presentation for the quarter and year ended ....30 May 2022
- Investor Presentation for the quarter ended on December ....24 Jan 2022
- Investor Presentation for the quarter ended on September, ....28 Oct 2021
Gujarat Terce Laboratories share news and announcements
Newest first. Page 1 of 11.
Aug 2026
21 Aug · Meeting
21 Aug · Meeting
21 Aug · Management
7 Aug · Results
7 Aug · Results
3 Aug · Board meeting
Meeting on 7 Aug 2026: quarterly results
Jul 2026
Jun 2026
1 Jun · Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
May 2026
30 May · Meeting
29 May · Meeting
29 May · Results
29 May · Management
29 May · Results
13 May · Board meeting
Meeting on 29 May 2026: annual general meeting and audited results
Feb 2026
24 Feb · Business
4 Feb · Results
Dec 2025
29 Dec · Board meeting
Meeting on 4 Feb 2026: quarterly results16 Dec · Announcement under Regulation 30 (LODR)-Allotment
Nov 2025
8 Nov · Results
3 Nov · Board meeting
Meeting on 8 Nov 2025: quarterly results
Sep 2025
1 Sep · Management
1 Sep · Management
1 Sep · Management
1 Sep · Board meeting
Aug 2025
22 Aug · Results
11 Aug · Results
4 Aug · Board meeting
Meeting on 11 Aug 2025: quarterly results
Jul 2025
17 Jul · Board meeting
16 Jul · Non-Applicability Of Regulation 27(2) Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On June 30, 2025.
9 Jul · Board meeting
Meeting on 17 Jul 2025: annual general meeting
May 2025
26 May · Results
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 1 Sep 2025Board or managers changeddown 0.37%−1.5 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−3.0 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 21 Aug 2025Board or managers changeddown 0.76%−0.7 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−2.4 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 22 May 2025Board or managers changedup 7.46%+8.1 pts vs Nifty 500market median 0.0% · five sessions −3.9% (−4.1 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 6 Sep 2022Board or managers changeddown 0.68%−0.8 pts vs Nifty 500market median 0.0% · five sessions −7.4% (−9.3 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 29 Oct 2021Board or managers changedup 1.00%+1.7 pts vs Nifty 500market median 0.0% · five sessions +17.7% (+16.5 pts vs Nifty 500) · volume 3.0× usual · The announcement
- 16 Jun 2021Board or managers changedup 4.32%+4.6 pts vs Nifty 500market median 0.0% · five sessions +4.3% (+4.8 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 9 Jan 2020Board or managers changedup 4.93%+3.4 pts vs Nifty 500market median 0.0% · five sessions −6.3% (−8.0 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 24 Jan 2019Board or managers changeddown 4.94%−5.0 pts vs Nifty 500market median 0.0% · five sessions −10.1% (−9.4 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 1 Oct 2018Board or managers changeddown 3.23%−2.8 pts vs Nifty 500market median 0.0% · five sessions +9.7% (+16.5 pts vs Nifty 500) · volume 10.5× usual · The announcement
- 31 Jul 2018Board or managers changeddown 3.71%−4.5 pts vs Nifty 500market median 0.0% · five sessions −7.6% (−9.0 pts vs Nifty 500) · volume 0.0× usual · The announcement